High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008)

The European Cancer Anaemia Survey (ECAS): A large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients

Heinz Ludwig, Simon Van Belle, Peter Barrett‐Lee et al. · European Journal of Cancer · 2004 · 912 citations

Cancer Epidemiology, Medicine, Cancer Management +6

Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review.

J. Jaime, Maribel Salas, Alexandra M. Ward et al. · PubMed · 2001 · 848 citations

Anemia as an independent prognostic factor for survival in patients with cancer

J. Jaime, Maribel Salas, Alexandra M. Ward et al. · Cancer · 2001 · 757 citations

Hematological Malignancy, Medicine, Lung Carcinoma +13

Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study Group.

George D. Demetri, Mark G. Kris, James L. Wade et al. · Journal of Clinical Oncology · 1998 · 756 citations

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

John A. Glaspy, Ronald Bukowski, Douglas Steinberg et al. · Journal of Clinical Oncology · 1997 · 705 citations